Page 3 - Zinsight Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Zinsight technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Zinsight Technology Today - Breaking & Trending Today

RedHill Biopharma Announces Q3/22 Results and Operational Highlights

Non-binding agreement in principle reached with HCR on sale of Movantik to extinguish all debt obligations, to facilitate growth Q3/22 Net revenues of $17.6. ....

United States , New York , State Of New York , Dror Ben Asher , Redhill Biopharma , Adi Frish , Kukbo Co , Redhill Biopharma Inc , University Of Tennessee , International Journal Of Nephrology , Redhill Biopharma Ltd , Company Annual Report On Form , Trademark Office , Development Expenses , Company Expanded Access Program , Centers For Disease , Zinsight Technology , European Commission , Supreme Court , Exchange Commission , Business Development , Animal Rule , Priority Review Voucher , Chief Executive Officer , Review Voucher , Administrative Expenses ,

45 companies named best workplaces in Singapore

SINGAPORE (The Straits Times/Asia News Network): Beyond reducing its carbon footprint, introducing electric vehicles to its existing delivery fleet has paid off for logistics company DHL Express Singapore. ....

Marina Bay , Singapore General , Heng Swee Keat , Bryan Koh , Straits Times Asia News Network , Insight Technology Solutions , Asia News Network , Christopher Ong , Great Place To Work , Marina Bay Sands , Asean Greater , Zinsight Technology , Deputy Prime Minister Heng Swee Keat , Coordinating Minister , Economic Policies ,

RedHill Biopharma Provides H1/22 Highlights and Q3/22 Estimates

Financial update: Q2/22: Net revenues of $18.3 million; Operating loss of $9.2 million; Cash balance[1] of $43.2 million as of June 30, 2022; Restated Q1/22:. ....

United States , New York , State Of New York , Dror Ben Asher , Redhill Biopharma , Adi Frish , Kukbo Co , University Of Tennessee , Redhill Biopharma Ltd , Development Expenses , Company Annual Report On Form , Trademark Office , Company Expanded Access Program , Redhill Inc , Prnewswire Redhill Biopharma Ltd , Centers For Disease , Company American Depositary Shares Adss , Cantor Fitzgerald Co , European Commission , Zinsight Technology , Exchange Commission , Supreme Court , Business Development , Hill Biopharma , Chief Executive Officer , Administrative Expenses ,

RedHill Biopharma Provides H1/22 Highlights and Q3/22 Estimates

Financial update: Q2/22: Net revenues of $18.3 million; Operating loss of $9.2 million; Cash balance[1] of $43.2 million as of June 30, 2022; Restated Q1/22:. ....

United States , New York , State Of New York , Dror Ben Asher , Redhill Biopharma , Adi Frish , Kukbo Co , University Of Tennessee , Redhill Biopharma Ltd , Development Expenses , Company Annual Report On Form , Trademark Office , Company Expanded Access Program , Redhill Inc , Prnewswire Redhill Biopharma Ltd , Centers For Disease , Company American Depositary Shares Adss , Cantor Fitzgerald Co , European Commission , Zinsight Technology , Exchange Commission , Supreme Court , Business Development , Hill Biopharma , Chief Executive Officer , Administrative Expenses ,

Financial update: Q2/22: Net revenues of $18.3 million; Operating loss of $9.2 million; Cash balance1 of $43.2 million as of June 30, 2022; Restated Q1/22: Net revenues of $13.1 million; Q3/22: Net revenues estimated2 to be between $16.5 million to $18.5 million; Operating loss estimated to be in the range of $5.5 million to $7.5 million; Q3/22 cash flow from operating activities is estimated positive for U.S. operations, before interest payments3 -- Commercial update: Upward trajectory continues with Talic

Financial update: Q2/22: Net revenues of $18.3 million; Operating loss of $9.2 million; Cash balance1

of $43.2 million as of June 30, 2022; Restated Q1/22: Net. | November 7, 2022 ....

United States , New York , State Of New York , Dror Ben Asher , Redhill Biopharma , Adi Frish , Kukbo Co , University Of Tennessee , Redhill Biopharma Ltd , Development Expenses , Company Annual Report On Form , Trademark Office , Company Expanded Access Program , Redhill Inc , Centers For Disease , Company American Depositary Shares Adss , Cantor Fitzgerald Co , European Commission , Zinsight Technology , Exchange Commission , Supreme Court , Business Development , Chief Executive Officer , Administrative Expenses , Cash Used , Operating Activities ,